NASDAQ: ARWR | Healthcare / Biotechnology / USA |
6.74 | +0.13 | +1.97%![]() | Vol 494 874 | 1Y Perf 339.87% |
Apr 26th, 2018 16:00 |
BID | 6.50 | ASK | 7.00 | ||
Open | 6.60 | Previous Close | 6.61 | ||
Pre-Market | - | After-Trading | 6.74 | ||
- -% | - -% |
Target Price | 7.75 | Analyst Rating | ![]() | |
Potencial % | 14.99 | Finscreener Ranking | ★★ ![]() | |
Insiders Trans % 3/6/12M | -100/-100/-100 | Value Ranking | ★+ ![]() | |
Insiders Value % 3/6/12M | -100/-100/-100 | Growth Ranking | ★★+ ![]() | |
Insiders Shares Cnt. % 3/6/12M | -100/-100/-100 | Income Ranking | — - | |
Market Cap (mil) | 585 | Earnings Rating | Strong Buy | |
Price Range Ratio 52wk % | 79.76 | Earnings Date | 8th May 2018 |
Today's Price Range 6.556.76 | 52wk Range 1.428.09 |
Summary:
Buy
Technical Indicators: | Buy |
Moving Averages: | Buy |
Performance | |||
---|---|---|---|
1 Month | -2.46% | ||
3 Months | 10.13% | ||
6 Months | 84.66% | ||
1 Year | 339.87% | ||
3 Years | -4.40% | ||
5 Years | 268.31% |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
Quick Ratio | 3.70 | |||
Current Ratio | 3.90 | |||
Long Term Debt to Total Capital | 0.03 | |||
Total Debt to Equity | 0.04 | |||
Interest Coverage | - | |||
Leverage Ratio | 1.30 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
Gross Margin | - | |||
EBIT Margin | -117.50 | |||
EBITDA Margin | -102.30 | |||
Pre-tax Profit Margin | -24 053.30 | |||
Profit Margin | -78.74 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
PE Ratio | - | |||
PB Ratio | 8.55 | |||
PS Ratios | 28.05 | |||
Price to Cash Flow | - | |||
Price to Free Cash Flow | -16.90 | |||
Cash Flow Per Share | -0.65 | |||
Price to Tangible Book | 11.93 | |||
Book Value per Share | 0.82 | |||
Enterprise Value (in ths.) | 556 691 |
Management Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
Return on Equity (5Y Avg) | -67.77 | |||
ROE last 12 Months | -38.94 | |||
Return on Assets (5Y Avg) | -48.20 | |||
ROA last 12 Months | -28.08 | |||
Return on Capital (5Y Avg) | -77.74 | |||
ROC last 12 Months | -40.87 | |||
Return on invested Capital Q | -16.79 | |||
Return on invested Capital Y | -37.73 | |||
Assets Turnover | 0.20 | |||
Receivables Turnover | 178.90 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
Revenue LTM (in ths.) | 21 566 | |||
Revenue per Share | 0.25 | |||
Revenue Growth 3 Years | 292.94 | |||
Revenue Growth 5 Years | 108.67 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
Dividend Yield | - | |||
Dividend Rate | - | |||
Dividend Growth 3 Years | - | |||
Dividend Growth 5 Years | - |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q01 2018 | -0.18 | -0.18 | 0.00 |
Q04 2017 | -0.12 | -0.14 | -16.67 |
Q03 2017 | -0.13 | -0.07 | 46.15 |
Q02 2017 | -0.12 | -0.08 | 33.33 |
Q01 2017 | -0.18 | -0.17 | 5.56 |
Q04 2016 | -0.33 | -0.31 | 6.06 |
Q03 2016 | -0.37 | -0.32 | 13.51 |
Q02 2016 | -0.37 | -0.35 | 5.41 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
3/2018 QR | -0.18 | 21.74 | Positive |
6/2018 QR | -0.17 | 26.09 | Positive |
9/2018 FY | -0.71 | 4.05 | Positive |
9/2019 FY | -0.51 | 39.29 | Positive |
Next Report Date | 8th May 2018 |
Estimated EPS Next Report | -0.18 |
Estimates Count | 5 |
EPS Growth Next 5 Years % | - |
Volume Overview | |
---|---|
Volume | 494 874 |
Shares Outstanding (in ths.) | 86 790 |
Trades Count | 2 832 |
Dollar Volume | 2 954 708 |
Avg. Volume | 1 744 548 |
Avg. Weekly Volume | 729 852 |
Avg. Monthly Volume | 1 052 083 |
Avg. Quarterly Volume | 1 374 536 |
Week | Month | Three Months | Six Months |
---|---|---|---|
Bearish Bullish 100%0% | Bearish Bullish 78%22% | Bearish Bullish 80%20% | Bearish Bullish 50%50% |
There are no comments yet.
![]() | ![]() | ![]() | ![]() | ![]() | ![]() |